Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Syngene International LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:539268NSE Symbol: SYNGENEP/E(TTM):59.07
ISIN Demat:INE398R01022Div & Yield %:1.79EPS(TTM):11.82
Book Value(Rs):104.1404189Market Cap ( Cr.):28107.14Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 3193.502601.402179.402011.901825.601423.10
Excise Duty0.000.000.000.000.000.00
Net Sales3193.502601.402179.402011.901825.601423.10
Other Income 70.90107.6099.60152.9075.1061.80
Stock Adjustments 42.0021.6025.20-0.80-26.0013.50
Total Income3306.402730.602304.202164.001874.701498.40
EXPENDITURE :      
Raw Materials 902.20770.60551.70518.60505.30395.20
Power & Fuel Cost69.2064.4057.4045.8041.3034.70
Employee Cost 812.20697.80641.50572.20465.40376.90
Other Manufacturing Expenses 208.30160.80140.60114.8098.1081.60
Selling and Administration Expenses 226.70157.90123.10132.80131.70119.30
Miscellaneous Expenses 82.6063.6020.3010.2022.20-35.50
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure2301.201915.101534.601394.401264.00972.20
Operating Profit1005.20815.50769.60769.60610.70526.20
Interest 45.2024.1027.7034.6032.3022.70
Gross Profit960.00791.40741.90735.00578.40503.50
Depreciation359.10309.70274.50219.30164.20131.40
Profit Before Tax600.90481.70467.40515.70414.20372.10
Tax115.6087.6046.8051.2086.4079.30
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax12.300.3016.9053.00-2.90-12.30
Reported Net Profit473.00393.80403.70411.50330.70305.10
Extraordinary Items 2.50-21.8425.1653.653.4816.05
Adjusted Net Profit470.50415.64378.54357.85327.22289.05
Adjst. below Net Profit -70.200.00-0.10-201.70-0.400.40
P & L Balance brought forward2573.302179.501775.901590.201284.001002.60
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.0024.1024.1024.10
P & L Balance carried down2976.102573.302179.501775.901590.201284.00
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %12.5010.000.000.005.0010.00
Earnings Per Share-Unit Curr11.789.8310.0910.2916.5415.26
Earnings Per Share(Adj)-Unit Curr11.789.8310.0910.298.277.63
Book Value-Unit Curr90.1682.1470.4654.3598.3686.01